Among OVs, talimogene laherparepvec (T-VEC), a modified herpes simplex virus type 1 (HSV-1) encoding granulocyte-macrophage colony-stimulating factor (GM-CSF), is the most clinically advanced and FDA-approved for metastatic melanoma (Coffin, 2016). Here, CSF2 is linked to metastatic melanoma.